Atypical haemolytic uremic syndrome from multiple missenses to a full-blown disease.
Filipe Santos MiraAna Luísa NunesAna Rita ElvasNuno OliveiraPublished in: BMJ case reports (2019)
A 72-year-old woman was admitted to the hospital because of dorsal, lumbar and lower abdomen pain that had started 4 days before. She had a history of age-related macular degeneration (treated with intraocular bevacizumab). Blood tests showed anaemia, thrombocytopaenia, acute kidney injury, elevated liver enzymes and total bilirubin (mainly because of the indirect fraction). Viral serologies and ADAMTS13 activity levels were normal, and stool testing was negative for Escherichia coli-producing Shiga toxins. E. coli was isolated in urine. Atypical haemolytic uremic syndrome triggered by a urinary tract infection or by the vascular endothelial growth factor-inhibitor bevacizumab were the most likely hypothesis. The patient started urgent plasmapheresis and dialysis that lasted for a total of 18 days. There was complete remission and recovery of kidney function allowing for treatment discontinuation, and she was discharged home. After 6 months of follow-up, she shows no signs of relapse.
Keyphrases
- escherichia coli
- vascular endothelial growth factor
- urinary tract infection
- age related macular degeneration
- case report
- acute kidney injury
- neuropathic pain
- healthcare
- chronic pain
- metastatic colorectal cancer
- spinal cord
- minimally invasive
- sars cov
- cardiac surgery
- endothelial cells
- chronic kidney disease
- pain management
- disease activity
- biofilm formation
- ulcerative colitis
- spinal cord injury
- systemic lupus erythematosus
- acute care
- rheumatoid arthritis
- pseudomonas aeruginosa
- iron deficiency
- multidrug resistant
- cataract surgery
- candida albicans